Page last updated: 2024-10-18

dihydroxyphenylalanine and Brain Vascular Disorders

dihydroxyphenylalanine has been researched along with Brain Vascular Disorders in 14 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"In patients with dystonia only, dopaminergic lesions were mostly confined to the ventromesial mesencephalon and red nucleus area, including the substantia nigra and nigrostriatal and cerebellothalamic fibers."5.30Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography. ( Agid, Y; Dormont, D; Dupel, C; Jedynak, P; Lehéricy, S; Marsault, C; Remy, P; Samson, Y; Serdaru, M; Veber, H; Vidailhet, M, 1999)
"In patients with dystonia only, dopaminergic lesions were mostly confined to the ventromesial mesencephalon and red nucleus area, including the substantia nigra and nigrostriatal and cerebellothalamic fibers."1.30Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography. ( Agid, Y; Dormont, D; Dupel, C; Jedynak, P; Lehéricy, S; Marsault, C; Remy, P; Samson, Y; Serdaru, M; Veber, H; Vidailhet, M, 1999)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-199013 (92.86)18.7374
1990's1 (7.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vidailhet, M1
Dupel, C1
Lehéricy, S1
Remy, P1
Dormont, D1
Serdaru, M1
Jedynak, P1
Veber, H1
Samson, Y1
Marsault, C1
Agid, Y1
Gehlen, W1
Van Woert, MH1
Weintraub, MI1
Araki, S1
Kameyama, M1
Matthews, WB1
Booker, HE1
Dahl, DS1
Yahr, MD1
Hamoen, AM1
Nicholson, WJ1
Bellastella, A1
Cafaro, MR1
Colucci, CF1
D'Alessandro, B1
Gasbarro, R1
Atarashi, J1
Terashi, A1
Gisselmann, A1
Lacroix, B1
Lamy, A1
Loche, D1

Reviews

6 reviews available for dihydroxyphenylalanine and Brain Vascular Disorders

ArticleYear
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].
    Medizinische Klinik, 1977, Aug-12, Volume: 72, Issue:32-33

    Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Di

1977
[Recent trend in neurology].
    Naika. Internal medicine, 1970, Volume: 25, Issue:1

    Topics: Cerebrovascular Disorders; Demyelinating Diseases; Diet Therapy; Dihydroxyphenylalanine; Epilepsy; H

1970
[Neurology].
    Naika. Internal medicine, 1972, Volume: 29, Issue:1

    Topics: Autonomic Nervous System; Brain Diseases; Cerebrovascular Disorders; Demyelinating Diseases; Dihydro

1972
Advances in neurology.
    The Practitioner, 1972, Volume: 209, Issue:252

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Anticonvulsants; Antihypertens

1972
L-dopa in neurological disease: current status.
    Research publications - Association for Research in Nervous and Mental Disease, 1972, Volume: 50

    Topics: Aged; Amyotrophic Lateral Sclerosis; Basal Ganglia Diseases; Cerebellar Diseases; Cerebrovascular Di

1972
[Recent progress in neurology].
    Naika. Internal medicine, 1971, Volume: 27, Issue:1

    Topics: Abdomen; Brain Death; Cerebrovascular Disorders; Demyelinating Diseases; Diffuse Cerebral Sclerosis

1971

Other Studies

8 other studies available for dihydroxyphenylalanine and Brain Vascular Disorders

ArticleYear
Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
    Archives of neurology, 1999, Volume: 56, Issue:8

    Topics: Adolescent; Aged; Cerebellum; Cerebrovascular Disorders; Corpus Striatum; Dihydroxyphenylalanine; Do

1999
Predicting the response to levodopa.
    Lancet (London, England), 1971, May-15, Volume: 1, Issue:7707

    Topics: Calcinosis; Capillaries; Central Nervous System; Cerebrospinal Fluid; Cerebrovascular Disorders; Dih

1971
Clinical neurology.
    Progress in neurology and psychiatry, 1971, Volume: 26

    Topics: Basal Ganglia; Cerebrovascular Disorders; Coma; Diagnosis, Differential; Dihydroxyphenylalanine; Hum

1971
Possible association between triphasic E.E.G. waves and disorder of dopaminergic systems.
    British medical journal, 1973, Aug-04, Volume: 3, Issue:5874

    Topics: Amantadine; Cerebrovascular Disorders; Creutzfeldt-Jakob Syndrome; Dihydroxyphenylalanine; Dopamine;

1973
Medicine in old age. Diseases of the motor system.
    British medical journal, 1973, Dec-15, Volume: 4, Issue:5893

    Topics: Activities of Daily Living; Aged; Basal Ganglia Diseases; Brain Stem; Bulbar Palsy, Progressive; Cer

1973
[Behavior of plasmatic HGH after stimulation with L-Dopa in normal elderly subjects and in subjects with cerebrovascular disorders: preliminary study].
    Bollettino della Societa italiana di biologia sperimentale, 1973, May-30, Volume: 49, Issue:10

    Topics: Adult; Age Factors; Aged; Aging; Cerebrovascular Disorders; Dihydroxyphenylalanine; Growth Hormone;

1973
[L Dopa and neurologic comas].
    La Nouvelle presse medicale, 1972, Sep-30, Volume: 1, Issue:34

    Topics: Adult; Aged; Cerebrovascular Disorders; Coma; Dihydroxyphenylalanine; Electroencephalography; Female

1972
A second report on Levodopa.
    The Medical letter on drugs and therapeutics, 1969, Sep-05, Volume: 11, Issue:18

    Topics: Amantadine; Arrhythmias, Cardiac; Cerebrovascular Disorders; Dihydroxyphenylalanine; Humans; Hypoten

1969